&Partners’s Exponent EXPO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$898K Sell
15,274
-2,267
-13% -$139K ﹤0.01% 1481
2026
Q1
$1.15M Sell
17,541
-261
-1% -$18.5K 0.01% 1217
2025
Q4
$1.24M Sell
17,802
-58
-0.3% -$4.07K 0.01% 1113
2025
Q3
$1.24M Buy
17,860
+980
+6% +$70K 0.01% 985
2025
Q2
$1.26M Buy
16,880
+2,533
+18% +$196K 0.01% 870
2025
Q1
$1.18M Buy
14,347
+1,754
+14% +$153K 0.01% 758
2024
Q4
$1.12M Buy
12,593
+2,303
+22% +$232K 0.01% 724
2024
Q3
$1.19M Buy
10,290
+5,024
+95% +$526K 0.02% 504
2024
Q2
$501K Buy
+5,266
New +$475K 0.02% 540

Other funds holding EXPO

&Partners's EXPO Position: Q2 2026 in Review

&Partners reduced its Exponent (EXPO) stake by 13% in Q2 2026, selling an estimated $139K and leaving 15,274 shares worth $898K. The position accounts for ﹤0.01% of the portfolio, ranked #1481.

&Partners first reported a position in EXPO in Q2 2024 and has held it in 9 quarters since. The position peaked at $1.26M in Q2 2025. 341 funds tracked by Wall St. Rank hold EXPO as of Q2 2026.

  • &Partners held 15,274 shares of Exponent worth $898K as of Q2 2026.
  • &Partners sold 2,267 Exponent shares in Q2 2026, an estimated $139K.
  • Exponent made up ﹤0.01% of &Partners's portfolio in Q2 2026, its #1481 holding.
  • &Partners first reported a position in Exponent in Q2 2024 and has held it in 9 quarters since.
  • &Partners's Exponent position peaked at $1.26M in Q2 2025.
  • 341 funds tracked by Wall St. Rank held Exponent as of Q2 2026.

Based on &Partners's 13F filing for Q2 2026, filed 14 Aug 2026.